Lily Zou serves as Independent Director of the Company. Ms. Zou currently serves as Chief Executive Officer of Fosun Pharma USA, Inc., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), a position which she has held since 2017. Prior to joining Fosun Pharma, Ms. Zou served as Executive Director of Business Development and Licensing for Sandoz, Inc., a Novartis division focusing on biosimilars and generics from 2009 to 2017. Ms. Zou previously held various positions at Arqule, Inc., Coley Pharmaceutical Group, Inc., Bristol-Myers Squibb Medical Imaging and Wyeth Pharmaceuticals. Ms. Zou earned a Ph.D in Microbiology and Immunology from Cornell University, MBA from MIT Sloan School of Management and a Bachelor of Science degree from Beijing University. The Governance Committee believes Ms. Zou’s extensive experience enhances the Board knowledge and skill in a key area. Ms. Zou is being nominated by the Governance Committee pursuant to an agreement between the Company and Fosun Pharma related to their Chinese joint venture.
As the Independent Director of Nature`s Sunshine Products, the total compensation of Lily Zou at Nature`s Sunshine Products is $114,875. There are 11 executives at Nature`s Sunshine Products getting paid more, with Terrence Moorehead having the highest compensation of $1,940,770.
Lily Zou is 50, she's been the Independent Director of Nature`s Sunshine Products since 2019. There are 11 older and 8 younger executives at Nature`s Sunshine Products. The oldest executive at Nature`s Sunshine Products, Inc. is Robert Mercer, 68, who is the Independent Director.
Lily's mailing address filed with the SEC is C/O NATURE'S SUNSHINE PRODUCTS, INC., 2901 WEST BLUEGRASS BLVD., LEHI, UT, 84043.
Over the last 21 years, insiders at Nature`s Sunshine Products have traded over $17,680,390 worth of Nature`s Sunshine Products stock and bought 2,750,800 units worth $34,431,833 . The most active insiders traders include Group Capital Management, L..., Partners Small Cap Value Lp... a Partners Small Cap Value Lp.... On average, Nature`s Sunshine Products executives and independent directors trade stock every 26 days with the average trade being worth of $265,216. The most recent stock trade was executed by Bryant J Yates on 6 June 2024, trading 3,068 units of NATR stock currently worth $46,940.
nature's sunshine products, a direct-selling company, manufactures and markets tablets and encapsulated herbal products, high-quality natural vitamins, food supplements, skin care and other complementary products. the company has operations in the united states, south korea, mexico, venezuela, japan, brazil, canada, central america, colombia, ecuador, peru, the united kingdom, israel and chile. the company also exports its products to several other countries, including argentina, australia, malaysia, new zealand, norway and the russian federation.
Nature`s Sunshine Products executives and other stock owners filed with the SEC include: